Basic information
- Standard SMILES
Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1- InChIKey
GECHUMIMRBOMGK-UHFFFAOYSA-N- Molecular formula
- C11H11N3O2S
- Average molar mass
- 249.29 g/mol
- Monoisotopic mass
- 249.05719778
Names & identifiers
- Preferred name
- Sulfapyridine
- IUPAC
- 4-amino-N-pyridin-2-ylbenzenesulfonamide
- English name
- Sulfapyridine
- Molecular formula
- C11H11N3O2S
- Molecular weight
- 249.29
Names & synonyms
Show more names
Database identifiers
- CAS
144-83-2- PubChem CID
- 5336
- DTXSID
DTXSID3026067- ChEMBL
CHEMBL700- ChEBI
CHEBI:132842- UNII
- Y5V2N1KE8U
- EC Number
- 205-642-7
- Nikkaji
- J5.831I
Properties
Computed structural properties
- XLogP
- 0
- Topological polar surface area
- 93.5 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 3
- Heavy atoms
- 17
- Formal charge
- 0
- Complexity
- 331
Physicochemical properties
- Melting point
- 191 · 191-193°C
- Boiling point
- 473.5 · 473.5±51.0 °C(Predicted)
- Density
- 1.322 · 1.3220 (rough estimate)
- refractive index
- 1.674 · 1.6740 (estimate)
- storage temp.
- Keep in dark place,Sealed in dry,Room Temperature
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- 8.48 · pKa 8.48(H2O t = 25 I = 0.05) (Uncertain)
- form
- Solid
- color
- White to Off-White
- Water Solubility
- 0.1 g/100 · <0.1 g/100 mL at 22 ºC
- Merck
- 14 · 14,8938
- BRN
- 222065 · 222065
- Stability
- Stable. Combustible. Protect from light. Incompatible with strong oxidizing agents.
- Major Application
- forensics and toxicologypharmaceutical (small molecule)
- InChI
- 1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
- InChIKey
- GECHUMIMRBOMGK-UHFFFAOYSA-N
- SMILES
- Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2
- CAS DataBase Reference
- 144 · 144-83-2(CAS DataBase Reference)
- FDA UNII
- 5 V2N1KE8U · Y5V2N1KE8U
- NIST Chemistry Reference
- Sulfapyridine(144-83-2)
- ATC code
- 1 EB04 · J01EB04
- EPA Substance Registry System
- Sulfapyridine (144-83-2)
- UNSPSC Code
- 41116107 · 41116107
- NACRES
- 24 · NA.24
- Symbol(GHS)
- 8 · GHS08
- Signal word
- Warning
- Hazard statements
- 361 fd · H361fd
- Precautionary statements
- 201 · P201-P202-P280-P308+P313-P405-P501
- Hazard Codes
- Xi
- Risk Statements
- 36 · 36/37/38
- Safety Statements
- 22 · 22-24/25-36-26
- WGK Germany
- 2 · 2
- RTECS
- 9625000 · DA9625000
- TSCA
- TSCA listed
- HazardClass
- IRRITANT
- HS Code
- 29350010 · 29350010
- Storage Class
- 11 · 11 - Combustible Solids
- Hazard Classifications
- 2 · Repr. 2
- Toxicity
- 50 orally · LD50 orally in mice: 7.5 mg/g (Wien)
- REACH Registrations
- Active
Safety & regulation
Safety data
- wgk
- 2
- tsca
- TSCA listed
- rtecs
- DA9625000
- hs_code
- 29350010
- Toxicity
- LD50 orally in mice: 7.5 mg/g (Wien)
- risk_code
- 36/37/38
- Signal word
- Warning
- Symbol(GHS)
- GHS08
- hazard_code
- Xi
- safety_code
- 22-24/25-36-26
- hazard_class
- IRRITANT
- Storage Class
- 11 - Combustible Solids
- Hazard statements
- H361fd
- REACH Registrations
- Active
- Hazard Classifications
- Repr. 2
- Precautionary statements
- P201-P202-P280-P308+P313-P405-P501
Chemistry & industry
Applications
DescriptionSulfapyridine is a sulfonamide antibiotic with antibacterial and anti-inflammatory activities. It is also a metabolite of sulfasalazine formed through bacterial conversion in the colon. It is active against strains of Y. enterocolitica and Salmonella (MICs = 3.1-25 and 25-100 μg/ml, respectively), as well as S. aureus (MBC = 0.8 μM). It is an inhibitor of recombinant P. carinii dihydropteroate synthetase (DHPS; IC50 = 0.18 μM). Sulfapyridine scavenges peroxyl radicals in an oxygen radical absorbance capacity (ORAC) assay. It inhibits histamine release induced by compound 48/80 from isolated rat peritoneal mast cells in a dose-dependent manner. Sulfapyridine (1 μg/kg) also inhibits compound 48/80-induced systemic allergic reaction in rats. Formulations containing sulfapyridine have previously been used in the treatment of dermatological conditions and ulcerative colitis.
UsesUsed in treatment of dermatitis herpetiformis; antibacterial.
Usesantibacterial, dermatitis herpetiformis therapy
General DescriptionSulfapyridine’s plasma half-life is 9 hours.This compound is a white, crystalline, odorless, and tastelesssubstance. It is stable in air but slowly darkens on exposureto light. It is soluble in water (1:3,500), in alcohol(1:440), and in acetone (1:65) at 25°C. It is freely soluble indilute mineral acids and aqueous solutions of sodium andpotassium hydroxide. The pKa is 8.4. Its outstanding effectin curing pneumonia was first recognized by Whitby; however,because of its relatively high toxicity, it has been supplantedlargely by sulfadiazine and sulfamerazine. Severalcases of kidney damage have resulted from acetylsulfapyridinecrystals deposited in the kidneys. It also causes severenausea in most patients. Because of its toxicity, it is usedonly for dermatitis herpetiformis.Sulfapyridine was the first drug to have an outstandingcurative action on pneumonia. It gave impetus to the studyof the whole class of N1 heterocyclically substituted derivativesof sulfanilamide.
General DescriptionOdorless or almost odorless white or yellowish-white crystalline powder. Very slightly bitter taste. Aqueous solution is neutral.
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers50 total
Additional notes
DefinitionChEBI: A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.
Related reactions
Linked notes
Loading…